- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 12, 2024 | 563.47M sh |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $987.44K |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $987.44K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $9.81M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | −$66.12K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $264.82K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $257.87K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $1.25M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.25M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $1.76M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $285.26K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $11.06M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $7.09M |
| Net Income | Q1 2024 · Dec 31, 2023 | −$303.2K |
| Net Income | Q1 2024 · Mar 31, 2023 | $0 |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 348.21M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $0 |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $0 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Operating Income | Q1 2024 · Mar 31, 2023 | $0 |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $0 |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $0 |